Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Fuji
Accenture
Julphar
Merck
QuintilesIMS

Generated: September 17, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,566,252

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,566,252 protect, and when does it expire?

Patent 9,566,252 protects OSPHENA and is included in one NDA.

This patent has forty-one patent family members in twenty-eight countries.

Summary for Patent: 9,566,252
Title:Method for the alleviation of dyspareunia in women
Abstract: This invention relates to a method for inhibition of skin atrophy, or epithelial or mucosal atrophy in women, or to a method for treatment or prevention of symptoms related to said atrophy, said method comprising administering to the woman an effective amount of the compound of formula (I) ##STR00001## or a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester thereof or a metabolite thereof.
Inventor(s): Halonen; Kaija (Rusko, FI), Kangas; Lauri (Lieto, FI), DeGregorio; Michael W. (Granite Bay, CA)
Assignee: HORMOS MEDICAL LTD. (Turku, FI)
Application Number:12/837,292
Patent Claim Types:
see list of patent claims
Use; Delivery;

Drugs Protected by US Patent 9,566,252

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Duchesnay OSPHENA ospemifene TABLET;ORAL 203505-001 Feb 26, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up TREATMENT OF DYSPAREUNIA ASSOCIATED WITH MENOPAUSE ➤ Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 9,566,252

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 300289 ➤ Sign Up
Australia 2001258449 ➤ Sign Up
Australia 5844901 ➤ Sign Up
Bulgaria 107472 ➤ Sign Up
Bulgaria 65943 ➤ Sign Up
Brazil 0112659 ➤ Sign Up
Canada 2416480 ➤ Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Covington
Baxter
Colorcon
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.